Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells
2019 · Genetic Testing and Molecular Biomarkers · 31 citations
https://doi.org/10.1089/gtmb.2018.0259
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
625
Citations
12
h-index
13
i10-index
Mengquan Li is an academic researcher from First Affiliated Hospital of Zhengzhou University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Breast Cancer Treatment Studies & MicroRNA in disease regulation. The author has an h-index of 12, co-authored 26 publications.
ORCID: 0000-0002-4046-1747Click to start Chat